319
Participants
Start Date
September 30, 2020
Primary Completion Date
June 27, 2022
Study Completion Date
August 9, 2022
SP-624
Oral capsule
Placebo
Oral capsule
Manhattan Behavioral Medicine, New York
Richmond Behavioral Associates, Staten Island
SPRI Clinical Trials, Brooklyn
Lehigh Center for Clinical Research, Allentown
CBH Health, Gaithersburg
New Hope Clinical Research, Charlotte
Clinical Trials of America, Hickory
Institute for Advanced Medical Research, Alpharetta
iResearch Atlanta, Decatur
Atlanta Center for Medical Research, Atlanta
Clinical Neuroscience Solutions, Inc., Jacksonville
Sarkis Clinical Trials, Gainesville
Clinical Neuroscience Solutions, Inc., Orlando
Innovative Clinical Research, Lauderhill
Clinical Neuroscience Solutions, Inc., Memphis
Midwest Clinical Research Center, Dayton
Capstone Clinical Research, Libertyville
American Medical Research, Chicago
Midwest Research Group, Saint Charles
Woodland International Research Group, Little Rock
Woodland Research Northwest, Rogers
Cutting Edge Research Group, Oklahoma City
Future Search Trials of Dallas, Dallas
Grayline Research Center, Wichita Falls
Red Oak Psychiatry Associates, Houston
Donald J. Garcia, Jr., MD, PA, Austin
MCB Clinical Research Centers, Colorado Springs
Alea Research, Phoenix
Altea Research Institute, Las Vegas
Collaborative Neuroscience Research, Torrance
Artemis Institute for Clinical Research, San Diego
Collaborative Neuroscience Research, Garden Grove
Pacific Research Partners, Oakland
Oregon Center for Clinical Investigations, Portland
Oregon Center for Clinical Investigations, Salem
Core Clinical Research, Everett
Hassman Research Institute, Berlin
Center for Emotional Fitness, Cherry Hill
Hassman Research Institute, Marlton
Sirtsei Pharmaceuticals, Inc.
INDUSTRY